Within the respiratory disease area, innovative treatments for chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis, lung cancer, allergic rhinitis and infantile ...

People with the lung disease COPD (chronic obstructive pulmonary disease) have a new treatment option: a multitasking ...

Carpets, fireworks, and hot tubs are some of the unexpected things that can hurt your lungs. Find out what you can do to prevent problems from these and other culprits.

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

Researchers from Teesside University and the National Institute for Health and Care Research (NIHR) Applied Research ...

This online certificate program helps professionals succeed in environments where Big Data and metrics are key. Hands-on courses in information design, data analytics and filtering, visualization best ...

Chronic Obstructive Pulmonary Disease (COPD) is a long-term respiratory condition that is not entirely reversible and is ...

SCMP’s multimedia collection of visual stories deep dive into the news and happenings in Hong Kong, China and Asia. Explore our award-winning interactives, data visualisations and animations to ...

and Sanofi SA, could mean another $6.4 billion-plus in sales by the end of the decade. Regulators cleared the drug as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD) ...

Dupixent is an “add-on” drug for COPD, meaning patients take it in addition to inhaled medication Dupixent isn’t approved as a stand-alone treatment for COPD. The U.S. Food and Drug ...

The approval makes COPD the sixth indication for the blockbuster treatment and makes Dupixent the first available biologic for the condition. As per a 27 September press announcement, Dupixent ...